To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004
Clinical trial NCT06169059 · COMPLETED
Trial details
- NCT number
- NCT06169059
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2023-11-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.